The radiofrequency ablation devices market size has grown rapidly in recent years. It will grow from $5.25 billion in 2025 to $5.91 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of cancer and chronic pain conditions, expansion of interventional treatment options, growing acceptance of thermal ablation therapies, availability of rf generator platforms, rising use of outpatient procedures.
The radiofrequency ablation devices market size is expected to see rapid growth in the next few years. It will grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing demand for image-guided oncology treatments, rising adoption of rf ablation in cardiology, expansion of ambulatory surgical procedures, growing focus on targeted pain management, increasing investment in advanced ablation technologies. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of disposable ablation catheters, growing integration of imaging-guided ablation systems, expansion of pain management applications, enhanced focus on precision tissue targeting.
Increasing chronic diseases are driving the growth of the radiofrequency ablation devices market. Chronic diseases are conditions that persist for a year or longer, requiring ongoing medical care and often limiting daily activities. Radiofrequency ablation devices are used to manage chronic and arthritic joint pain and are also employed to reduce the size of tumors, nodules, or other abnormal growths. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 35 million new cancer cases were projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the radiofrequency ablation devices market.
Major companies operating in the radiofrequency ablation devices market are focusing on introducing advanced medical devices, such as the ELIOSTAR Balloon Ablation Catheter, to strengthen their competitive position. The ELIOSTAR Balloon Ablation Catheter is designed for cardiac ablation procedures, utilizing innovative technology to treat arrhythmias and enhance precision in electrophysiological interventions. For instance, in April 2023, Compal Electronics, a Taiwan-based electronics company, launched AblatePal, a radiofrequency ablation system for percutaneous and intraoperative coagulation and ablation of soft tissue. The system uses heat generated by electrical resistance to cauterize tumors and induce necrosis, while advanced cooling technology prevents damage to surrounding healthy tissue, reduces wound size, and shortens hospital stays.
In June 2023, Avanos Medical, Inc., a US-based medical technology company, acquired Diros Technology Inc. for $53 million. Through this acquisition, Avanos aims to expand its chronic pain treatment offerings by integrating Diros’s Trident RF tined probe technology with its existing COOLIEF cooled RF products, broadening its minimally invasive, non-opioid pain management portfolio. Diros Technology is a Canada-based developer of radiofrequency ablation devices.
Major companies operating in the radiofrequency ablation devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, AngioDynamics Inc, AtriCure Inc, Stryker Corporation, Smith and Nephew plc, CONMED Corporation, Hologic Inc, Olympus Corporation, BIOTRONIK SE and Co KG, Baylis Medical Company Inc, Avanos Medical Inc, Cosman Medical Inc, Lepu Medical Technology Co Ltd, RF Medical Co Ltd, Gynesonics Inc, Cutera Inc, MicroPort Scientific Corporation, Merit Medical Systems Inc, ENDO-FLEX GmbH, Bramsys Industria e Comercio Ltd.
North America was the largest region in the radiofrequency ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiofrequency ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiofrequency ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the radiofrequency ablation devices market by increasing costs of imported rf generators, ablation catheters, electrodes, imaging components, and electronic control units. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces export cost pressures. These tariffs are raising procedural equipment costs and influencing capital purchasing cycles. However, they are also encouraging domestic manufacturing of disposables, regional assembly of rf systems, and innovation in cost-optimized ablation platforms.
The radiofrequency ablation devices market research report is one of a series of new reports that provides radiofrequency ablation devices market statistics, including radiofrequency ablation devices industry global market size, regional shares, competitors with a radiofrequency ablation devices market share, detailed radiofrequency ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the radiofrequency ablation devices industry. This radiofrequency ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Radiofrequency ablation devices represent medical instruments that produce heat through medium-frequency alternating currents to ablate or eliminate abnormal tissue. These devices are employed in the destruction of cancerous tissue and the management of chronic pain by interrupting pain impulses.
The primary types of radiofrequency ablation devices include disposable equipment, reusable equipment, and capital equipment. Disposable equipment denotes medical devices designed for a single use or short duration. These are utilized in various applications, including oncology, cardiology and cardiac rhythm management, gynecology, pain management, among others, and are deployed by different end-users, such as hospitals, ambulatory surgical centers, and others.
The radiofrequency ablation devices market consists of sales of catheters, thermopads, and hard tissue introducers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The radiofrequency ablation devices market size is expected to see rapid growth in the next few years. It will grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing demand for image-guided oncology treatments, rising adoption of rf ablation in cardiology, expansion of ambulatory surgical procedures, growing focus on targeted pain management, increasing investment in advanced ablation technologies. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of disposable ablation catheters, growing integration of imaging-guided ablation systems, expansion of pain management applications, enhanced focus on precision tissue targeting.
Increasing chronic diseases are driving the growth of the radiofrequency ablation devices market. Chronic diseases are conditions that persist for a year or longer, requiring ongoing medical care and often limiting daily activities. Radiofrequency ablation devices are used to manage chronic and arthritic joint pain and are also employed to reduce the size of tumors, nodules, or other abnormal growths. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 35 million new cancer cases were projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the radiofrequency ablation devices market.
Major companies operating in the radiofrequency ablation devices market are focusing on introducing advanced medical devices, such as the ELIOSTAR Balloon Ablation Catheter, to strengthen their competitive position. The ELIOSTAR Balloon Ablation Catheter is designed for cardiac ablation procedures, utilizing innovative technology to treat arrhythmias and enhance precision in electrophysiological interventions. For instance, in April 2023, Compal Electronics, a Taiwan-based electronics company, launched AblatePal, a radiofrequency ablation system for percutaneous and intraoperative coagulation and ablation of soft tissue. The system uses heat generated by electrical resistance to cauterize tumors and induce necrosis, while advanced cooling technology prevents damage to surrounding healthy tissue, reduces wound size, and shortens hospital stays.
In June 2023, Avanos Medical, Inc., a US-based medical technology company, acquired Diros Technology Inc. for $53 million. Through this acquisition, Avanos aims to expand its chronic pain treatment offerings by integrating Diros’s Trident RF tined probe technology with its existing COOLIEF cooled RF products, broadening its minimally invasive, non-opioid pain management portfolio. Diros Technology is a Canada-based developer of radiofrequency ablation devices.
Major companies operating in the radiofrequency ablation devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, AngioDynamics Inc, AtriCure Inc, Stryker Corporation, Smith and Nephew plc, CONMED Corporation, Hologic Inc, Olympus Corporation, BIOTRONIK SE and Co KG, Baylis Medical Company Inc, Avanos Medical Inc, Cosman Medical Inc, Lepu Medical Technology Co Ltd, RF Medical Co Ltd, Gynesonics Inc, Cutera Inc, MicroPort Scientific Corporation, Merit Medical Systems Inc, ENDO-FLEX GmbH, Bramsys Industria e Comercio Ltd.
North America was the largest region in the radiofrequency ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiofrequency ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiofrequency ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the radiofrequency ablation devices market by increasing costs of imported rf generators, ablation catheters, electrodes, imaging components, and electronic control units. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces export cost pressures. These tariffs are raising procedural equipment costs and influencing capital purchasing cycles. However, they are also encouraging domestic manufacturing of disposables, regional assembly of rf systems, and innovation in cost-optimized ablation platforms.
The radiofrequency ablation devices market research report is one of a series of new reports that provides radiofrequency ablation devices market statistics, including radiofrequency ablation devices industry global market size, regional shares, competitors with a radiofrequency ablation devices market share, detailed radiofrequency ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the radiofrequency ablation devices industry. This radiofrequency ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Radiofrequency ablation devices represent medical instruments that produce heat through medium-frequency alternating currents to ablate or eliminate abnormal tissue. These devices are employed in the destruction of cancerous tissue and the management of chronic pain by interrupting pain impulses.
The primary types of radiofrequency ablation devices include disposable equipment, reusable equipment, and capital equipment. Disposable equipment denotes medical devices designed for a single use or short duration. These are utilized in various applications, including oncology, cardiology and cardiac rhythm management, gynecology, pain management, among others, and are deployed by different end-users, such as hospitals, ambulatory surgical centers, and others.
The radiofrequency ablation devices market consists of sales of catheters, thermopads, and hard tissue introducers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Radiofrequency Ablation Devices Market Characteristics
3. Radiofrequency Ablation Devices Market Supply Chain Analysis
4. Global Radiofrequency Ablation Devices Market Trends and Strategies
5. Radiofrequency Ablation Devices Market Analysis of End Use Industries
7. Global Radiofrequency Ablation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Radiofrequency Ablation Devices Total Addressable Market (TAM) Analysis for the Market
9. Radiofrequency Ablation Devices Market Segmentation
10. Radiofrequency Ablation Devices Market Regional and Country Analysis
11. Asia-Pacific Radiofrequency Ablation Devices Market
12. China Radiofrequency Ablation Devices Market
13. India Radiofrequency Ablation Devices Market
14. Japan Radiofrequency Ablation Devices Market
15. Australia Radiofrequency Ablation Devices Market
16. Indonesia Radiofrequency Ablation Devices Market
17. South Korea Radiofrequency Ablation Devices Market
18. Taiwan Radiofrequency Ablation Devices Market
19. South East Asia Radiofrequency Ablation Devices Market
20. Western Europe Radiofrequency Ablation Devices Market
21. UK Radiofrequency Ablation Devices Market
22. Germany Radiofrequency Ablation Devices Market
23. France Radiofrequency Ablation Devices Market
24. Italy Radiofrequency Ablation Devices Market
25. Spain Radiofrequency Ablation Devices Market
26. Eastern Europe Radiofrequency Ablation Devices Market
27. Russia Radiofrequency Ablation Devices Market
28. North America Radiofrequency Ablation Devices Market
29. USA Radiofrequency Ablation Devices Market
30. Canada Radiofrequency Ablation Devices Market
31. South America Radiofrequency Ablation Devices Market
32. Brazil Radiofrequency Ablation Devices Market
33. Middle East Radiofrequency Ablation Devices Market
34. Africa Radiofrequency Ablation Devices Market
36. Radiofrequency Ablation Devices Market Competitive Landscape and Company Profiles
37. Radiofrequency Ablation Devices Market Other Major and Innovative Companies
40. Radiofrequency Ablation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Radiofrequency Ablation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses radiofrequency ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for radiofrequency ablation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiofrequency ablation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Disposable Equipment; Reusable Equipment2) By Application: Oncology; Cardiology And Cardiac Rhythm Management; Gynecology; Pain Management
3) By End-User: Hospitals; Ambulatory Surgical Centers
Subsegments:
1) By Disposable Equipment: Ablation Catheters; Electrode Pads; Temperature Probes2) By Reusable Equipment: RF Generators; Handpieces
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; AngioDynamics Inc; AtriCure Inc; Stryker Corporation; Smith and Nephew plc; CONMED Corporation; Hologic Inc; Olympus Corporation; BIOTRONIK SE and Co KG; Baylis Medical Company Inc; Avanos Medical Inc; Cosman Medical Inc; Lepu Medical Technology Co Ltd; RF Medical Co Ltd; Gynesonics Inc; Cutera Inc; MicroPort Scientific Corporation; Merit Medical Systems Inc; ENDO-FLEX GmbH; Bramsys Industria e Comercio Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Radiofrequency Ablation Devices market report include:- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- AngioDynamics Inc
- AtriCure Inc
- Stryker Corporation
- Smith and Nephew plc
- CONMED Corporation
- Hologic Inc
- Olympus Corporation
- BIOTRONIK SE and Co KG
- Baylis Medical Company Inc
- Avanos Medical Inc
- Cosman Medical Inc
- Lepu Medical Technology Co Ltd
- RF Medical Co Ltd
- Gynesonics Inc
- Cutera Inc
- MicroPort Scientific Corporation
- Merit Medical Systems Inc
- ENDO-FLEX GmbH
- Bramsys Industria e Comercio Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.91 Billion |
| Forecasted Market Value ( USD | $ 9.55 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
